In May 2020, 3M’s Drug Delivery Systems business was acquired by Altaris Capital Partners and renamed Kindeva Drug Delivery. The business has >50 years’ pharma CDMO experience across inhalation, nasal, transdermal and microneedle-based drug delivery systems.
Associated CompaniesKindeva Drug Delivery
2501 Hudson Rd
The business, in which 3M retains a 17% minority holding, has >50 years’ pharmaceutical development, commercialisation and contract manufacturing services experience across the inhalation, nasal, transdermal and microneedles.
Visit Kindeva’s Company Listing.